Clinical Trials & Pharmacovigilance

Clinical trials and pharmacovigilance work hand in hand to ensure drug safety and efficacy. Clinical trials rigorously test new treatments under controlled conditions, while pharmacovigilance continues safety monitoring post-approval, detecting and assessing adverse effects. Together, they safeguard public health, optimize therapeutic strategies, and contribute to informed decision-making in healthcare.

Clinical trials and pharmacovigilance are interconnected in ensuring drug safety and effectiveness. Clinical trials test new treatments under controlled environments, while pharmacovigilance monitors these treatments post-market to identify any adverse effects. Together, they form a comprehensive approach to drug regulation and patient safety, continuously evaluating and improving therapeutic practices.

    Related Conference of Clinical Trials & Pharmacovigilance

    July 27-28, 2026

    19th World Drug Delivery Summit

    Paris, France
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 14-15, 2026

    6th International Conference on Pharmaceutical Chemistry

    Paris, France
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France
    November 26-27, 2026

    5th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland
    November 26-27, 2026

    5th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    December 14-15, 2026

    5th Global Summit on Pharmaceutical Research

    Paris, France
    January 26-27, 2027

    22nd Annual Meet on Pharmaceutical Sciences

    Paris, France
    April 27-28, 2027

    10th European Biopharma Congress

    Paris, France

    Clinical Trials & Pharmacovigilance Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in